HomeGMAB • NASDAQ
add
Genmab
Nakaraang pagsara
$22.19
Sakop ng araw
$22.00 - $22.24
Sakop ng taon
$19.85 - $31.96
Market cap
14.65B USD
Average na Volume
1.06M
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 5.54B | 17.57% |
Gastos sa pagpapatakbo | 3.15B | 6.78% |
Net na kita | 1.27B | -39.83% |
Net profit margin | 22.85 | -48.82% |
Kita sa bawat share | 0.29 | -38.43% |
EBITDA | 2.20B | 26.09% |
Aktuwal na % ng binabayarang buwis | 26.35% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 17.32B | -37.08% |
Kabuuang asset | 39.66B | 12.55% |
Kabuuang sagutin | 7.74B | 87.54% |
Kabuuang equity | 31.92B | — |
Natitirang share | 63.51M | — |
Presyo para makapag-book | 0.04 | — |
Return on assets | 13.53% | — |
Return on capital | 16.33% | — |
Cash Flow
Net change in cash
| (DKK) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 1.27B | -39.83% |
Cash mula sa mga operasyon | 2.03B | -0.20% |
Cash mula sa pag-invest | 224.00M | -77.78% |
Cash mula sa financing | -276.00M | -1,480.00% |
Net change in cash | 2.01B | -40.84% |
Malayang cash flow | 1.42B | 9.09% |
Tungkol
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, the Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, and Genmab K.K. in Tokyo, Japan. Genmab is a dual-listed company with shares traded on both the Copenhagen Stock Exchange in Denmark and the NASDAQ Global Select Market in the US. Wikipedia
Itinatag
1999
Website
Mga Empleyado
2,635
